Abstract
111 children with heights below 2.5 SD fcr age (Tanner) were identified by screening of 7500 children, 6-14 years of age, in the Rehovot region. The total population of this age group is 40,000 in the area studied. The 111 children of short stature (ss) included: 8 skeletal disease, 2 Down Syndrome, 4 Thalassemia, 4 Turner, 3 celiac, 4 classical growth hormon deficiency (CGHD), 4 intrauterine growth retardation, 4 systemic disease, and 78 without obvious underlying disease. In 35 of the 78 subjects the 24 h. integrated concentration of growth hormone (ICGH) was in the hypopituitary range (< 3.2 ng/ml) and were thus diagnosed as having Neurosecretory Dysfunction (NSD). A one-year growth response to somatropin (recombinant GH, BioTropin, Bio-Technology General, Israel) of NSD patients, 19 of whom remained prepubertal throughout the study, was compared to CGHD patients. The response of both groups was similar, as summarized below:
The frequency of NSD patients (45%) among ss without underlying pathology in the Rehovot region was consistent with that found in NSD diagnosed patients referred from other Israeli centers (35/78 and 99/221, respectively). The overall frequency of NSD in the population screened was 4/1000 children.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zadik, Z., Landau, H., Hocberg, Z. et al. 88 FREQUENCY OF NEUROSECRETORY DYSFUNCTION (NSD) IN REHOVOT, ISRAEL. Pediatr Res 24, 531 (1988). https://doi.org/10.1203/00006450-198810000-00109
Issue Date:
DOI: https://doi.org/10.1203/00006450-198810000-00109